ibandronic acid has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Hua, Q; Li, H; Wang, L; Xu, T | 1 |
| Chen, G; Chen, Y; Deng, J; Fan, D; Liu, H; Lu, Z; Mok, GSP; Yang, J | 1 |
2 other study(ies) available for ibandronic acid and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
| Article | Year |
|---|---|
177Lu-DOTA-IBA Therapy in Prostate Cancer With Bone Metastases.
Topics: Bone Neoplasms; Humans; Ibandronic Acid; Male; Prostatic Neoplasms; Radiopharmaceuticals | 2023 |
Biodistribution and Internal Dosimetry of 68 Ga-DOTA-IBA PET Imaging for Patients With Bone Metastases.
Topics: Bone Neoplasms; Humans; Ibandronic Acid; Positron-Emission Tomography; Radiometry; Tissue Distribution | 2023 |